What's new? Log in Free sign up

Filing search / Lineage Cell Therapeutics, Inc. / "Pandemic"

Search information

Lineage Cell Therapeutics, Inc.

Companies

"Pandemic"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

32 results

Newest first Best match first

LCTX Lineage Cell Therapeutics, Inc.

Quarterly report

during the COVID pandemic. The company qualified for this credit due to a decline in the quarterly revenue during 2020 and 2021 as compared to the same … markets in the United States and worldwide, public health emergencies such as the COVID-19 pandemic, geopolitical conflicts, political and economic

8 Aug 24

4:15pm

LCTX Lineage Cell Therapeutics, Inc.

Quarterly report

was designed by the U.S. Treasury Department to assist businesses that retained employees during the COVID pandemic. For the three months ended March 31 … such as the COVID-19 pandemic, geopolitical conflicts, political and economic instability, inflation and relatively high interest rates, and other macroeconomic

9 May 24

4:15pm

LCTX Lineage Cell Therapeutics, Inc.

Prospectus supplement for primary offering

to recruit and retain key personnel; the potential effects of the COVID-19 pandemic on our operations; our expected use of proceeds from any offering under

LCTX Lineage Cell Therapeutics, Inc.

to the statute, will remain in effect through 2031, except for a temporary suspension from May 1, 2020 through March 31, 2022 due to the COVID-19 pandemic … , inflation, relatively high interest rates, public health emergencies such as the COVID-19 pandemic, geopolitical conflicts including the Israel-Hamas war

7 Mar 24

4:21pm

LCTX Lineage Cell Therapeutics, Inc.

Prospectus supplement for primary offering

; the effects on our operations of pandemics and other public health emergencies, including the recent COVID-19 pandemic, geopolitical conflicts … the proprietary rights of third parties; our ability to recruit and retain key personnel; the potential effects of the COVID-19 pandemic on our operations

Quarterly report

9 Nov 23

4:15pm

Quarterly report

10 Aug 23

4:16pm

Quarterly report

11 May 23

4:15pm

Quarterly report

10 Nov 22

4:16pm

Quarterly report

11 Aug 22

4:16pm

Quarterly report

12 May 22

4:16pm

hrujrl15z72uqrl9xoqu

Definitive proxy

29 Apr 22

4:06pm

10 Mar 22

4:37pm

LINEAGE CELL THERAPEUTICS REPORTs FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

hcze48eshvw55pzkyuqa

Prospectus supplement for primary offering

9efb5l5n7j51tcue5p7

Quarterly report

10 Nov 21

4:16pm

Quarterly report

12 Aug 21

4:21pm

2c6hcvf3zq0 vnh45o

Definitive proxy

3 Aug 21

5:00pm

a7bnptbexo8r 962

Quarterly report

13 May 21

4:21pm

Prev
1
2
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.